Future Science Group
Browse
Supplementary_Figure_1-revised.tif (547.48 kB)

Association of serum YKL-40 change with prognosis in acute ischemic stroke patients complicated with diabetes mellitus - Supplementary Figure 1

Download (547.48 kB)
Version 2 2023-06-15, 14:09
Version 1 2023-06-15, 14:09
figure
posted on 2023-06-15, 14:09 authored by Guang Hao, Jian Sun, Tingting Zhong, Qian Xue, Yu’an Zou

Objective: This study intended to explore the serum YKL-40 change and its prognostic implication in acute

ischemic stroke (AIS) patients with diabetes mellitus (DM). Methods: YKL-40 was detected from serum by

ELISA in 121 AIS patients with DM at baseline, day (D)1, D3, D7 and D30 after disease onset. Results: YKL-

40 increased from baseline to D3, then decreased until D30 (p < 0.001). Notably, 20.7% of patients had

stroke recurrence, and 6.6% of patients died during follow-up. YKL-40 at D1 (p = 0.043), D7 (p = 0.007)

and D30 (p = 0.001) predicted higher stroke recurrence risk; additionally, YKL-40 at D3 (p = 0.010), D7

(p = 0.007) and D30 (p = 0.002) estimated higher mortality risk. Conclusion: Serum YKL-40 has a prognostic

effect on the management of AIS patients with DM.

History

Usage metrics

    Biomarkers in Medicine

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC